» Articles » PMID: 37376644

Viral Infections and Schizophrenia: A Comprehensive Review

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2023 Jun 28
PMID 37376644
Authors
Affiliations
Soon will be listed here.
Abstract

Schizophrenia is a complex mental disorder with multiple genetic and environmental factors contributing to its pathogenesis. Viral infections have been suggested to be one of the environmental factors associated with the development of this disorder. We comprehensively review all relevant published literature focusing on the relationship between schizophrenia and various viral infections, such as influenza virus, herpes virus 1 and 2 (HSV-1 and HSV-2), cytomegalovirus (CMV), Epstein-Barr virus (EBV), retrovirus, coronavirus, and Borna virus. These viruses may interfere with the normal maturation of the brain directly or through immune-induced mediators, such as cytokines, leading to the onset of schizophrenia. Changes in the expression of critical genes and elevated levels of inflammatory cytokines have been linked to virally-induced infections and relevant immune activities in schizophrenia. Future research is necessary to understand this relationship better and provide insight into the molecular mechanisms underlying the pathophysiology of schizophrenia.

Citing Articles

First-Episode Psychosis incidence pre-, during, and post-COVID-19 pandemic: a six-year natural quasi-experimental study in South London.

Quattrone A, Petkari E, Spinazzola E, Leung P, Li Z, Stewart R EClinicalMedicine. 2025; 81:103086.

PMID: 40040861 PMC: 11876906. DOI: 10.1016/j.eclinm.2025.103086.


Acute Schizophrenia-like Psychotic Disorder Against the Background of COVID-19.

Bravve L, Kaydan M, Kostyuk G Medicina (Kaunas). 2025; 61(2).

PMID: 40005415 PMC: 11857278. DOI: 10.3390/medicina61020298.


Chronic exposure to glucocorticoids amplifies inhibitory neuron cell fate during human neurodevelopment in organoids.

Dony L, Krontira A, Kaspar L, Ahmad R, Demirel I, Grochowicz M Sci Adv. 2025; 11(7):eadn8631.

PMID: 39951527 PMC: 11827642. DOI: 10.1126/sciadv.adn8631.


Viruses and psychiatric disorders: We have not crossed the borderline from hypothesis to proof yet (Review).

Siafakas N, Anastassopoulou C, Pournaras S, Tsakris A, Alevizakis E, Kympouropoulos S Mol Med Rep. 2025; 31(3.

PMID: 39749697 PMC: 11711936. DOI: 10.3892/mmr.2024.13426.


Transient Psychotic Relapse Following COVID-19 in a Stable Schizophrenia Patient on Paliperidone Palmitate: A Case Report.

Bokhari S, Karaman M, Thalitaya M Cureus. 2024; 16(11):e74661.

PMID: 39735104 PMC: 11681963. DOI: 10.7759/cureus.74661.


References
1.
Albrecht P, Torrey E, Boone E, HICKS J, Daniel N . Raised cytomegalovirus-antibody level in cerebrospinal fluid of schizophrenic patients. Lancet. 1980; 2(8198):769-72. DOI: 10.1016/s0140-6736(80)90386-4. View

2.
Wang Y, Jia J, Wang Y, Li F, Song X, Qin S . Roles of HSV-1 infection-induced microglial immune responses in CNS diseases: friends or foes?. Crit Rev Microbiol. 2019; 45(5-6):581-594. DOI: 10.1080/1040841X.2019.1660615. View

3.
Boin F, Zanardini R, Pioli R, Altamura C, Maes M, Gennarelli M . Association between -G308A tumor necrosis factor alpha gene polymorphism and schizophrenia. Mol Psychiatry. 2001; 6(1):79-82. DOI: 10.1038/sj.mp.4000815. View

4.
Marcelis M, Navarro-Mateu F, Murray R, Selten J, van Os J . Urbanization and psychosis: a study of 1942-1978 birth cohorts in The Netherlands. Psychol Med. 1998; 28(4):871-9. DOI: 10.1017/s0033291798006898. View

5.
Egbujo C, Sinclair D, Borgmann-Winter K, Arnold S, Turetsky B, Hahn C . Molecular evidence for decreased synaptic efficacy in the postmortem olfactory bulb of individuals with schizophrenia. Schizophr Res. 2015; 168(1-2):554-62. PMC: 5119750. DOI: 10.1016/j.schres.2015.07.026. View